Poster Abstract Session:
52. HIV Co-morbidities
Thursday, October 3, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Tracks: HIV-STD-TB

Presentations:

319
High Rates of Developing Multimorbidity Shortly After HIV-Seroconversion
Nancy Crum-Cianflone, MD MPH ; Octavio Mesner, MS ; Ionut Bebu, PhD ; Anuradha Ganesan, MD ; Edmund Tramont, MD ; Brian Agan, MD

320
Post-Acute Coronary Syndrome Heart Failure in HIV-infected Patients
Philip Lam, MD ; John Meriwether, MD ; Vasilios Papademetriou, MD ; Angelike P. Liappis, MD
Posters
  • IDSA_HIVCM_FINAL_9 24 rev.pdf (561.7 kB)

  • 321
    Vitamin D suppplementation Increases Vitamin D levels but does not imrpove inflammatory markers in HIV Infected women: A Chicago Women's Interagency HIVStudy (WIHS) study
    Oluwatoyin Adeyemi, MD ; Anna Hotton, PhD, MPH ; Mariam Aziz, MD ; Kathleen Weber ; Britt Livak, MPH ; Audrey French, MD ; Crystal Winston ; Joan Swiatek ; Karen Fodor ; Mardge Cohen, MD

    322
    Pilot Study to Evaluate Intramyocardial Lipid Accumulation in HIV+ Patients Receiving Highly Active Antiretroviral Therapy (HAART)
    David Tellalian, MD ; Lidia Szczepaniak, PhD ; David Ramirez ; Michael D. Nelson, PhD ; Roya Yumul, MD, PhD ; John Hsih, MD ; Troy Labounty, MD ; Debiao Li ; Antonio Hernandez Conte, MD, MBA ; W. David Hardy, MD

    323
    Comorbidity Prevalence and its Influence on Non-ARV Comedication Burden among HIV positive Patients
    Nana Koram, MPH, PhD ; Vani Vannappagari, MBBS, MPH, PhD ; Tim Sampson, BSc (Hons) ; Catherine Panozzo, MPH

    324
    Current Alcohol and Substance Use in HIV-infected and HIV/HCV-co-infected Patients in Routine Clinical Care across the U.S
    Jennifer C Ling, MD ; Carla V. Rodriguez, PhD ; Matthew Mimiaga, MPH, ScD ; Kenneth Mayer, MD ; Joseph Merrill, MD, MPH ; David Pantalone, PhD ; Geetanjali Chander, MD, MPH ; Mary E Mccaul, PhD ; Heidi Hutton, PhD ; Karen Cropsey, PsyD ; Michael J. Mugavero, MD, MHSc ; Katerina A Christopoulos, MD MPH ; W. Christopher Mathews, MD, MSPH ; Greer A. Burkholder, MD ; Michael S. Saag, MD ; Mari Kitahata, MD, MPH ; Heidi M. Crane, MD, MPH

    326
    Alcohol Use and its Association with CD4 and VL in a HAART Treated Population of HIV Sero-positive DoD Beneficiaries
    Grace E Macalino, PhD ; Ionut Bebu, PhD ; Octavio Mesner, MS ; Jason Okulicz, MD ; Mary Bavaro, MD ; Anuradha Ganesan, MBBS, MPH ; Jessie Glasser, MD, MPH

    327
    Posters
  • 327_IDWPoster.pdf (1.7 MB)

  • 328
    Colorectal Cancer Incidence and Screening in U.S. Medicaid Patients with and without HIV Infection
    Florence Momplaisir, MD ; Sara Keller, MD, MPH ; Vincent Lo Re III, MD, MSCE ; Craig Newcomb, MS ; Qing Liu, PhD ; Sarah Ratcliffe ; Judith Long, MD
    Posters
  • IDSA HIV Medicaid poster2.pdf (36.9 kB)

  • 329
    Assessing Vitamin D Testing and Supplementation Patterns in a Large Inner City Clinic
    Jose Gonzales Zamora, MD ; Anna Hotton, PhD, MPH ; Blake Max, PharmD ; Oluwatoyin Adeyemi, MD
    Posters
  • vitamin D poster.pdf (98.8 kB)

  • 330
    Trends in Hospital Mortality Among HIV-infected Patients During the Antiretroviral Therapy Era, 1995-2011
    Annie Cowell, MD MPH ; Sheela Shenoi, MD, MPH ; Tassos Kyriakides, PhD ; Lydia Barakat, MD

    331
    Comparing Cardiovascular Disease (CVD) Risk Scores Among HIV-Infected Patients in the CNICS Cohort
    Robin Nance ; J.A.C. Delaney, PhD ; Susan Heckbert, MD ; Matthew Budoff, MD ; Pathmaja Paramsothy, MD ; Carl Grunfeld, MD, PhD ; Greer A. Burkholder, MD ; James H. Willig, MD, MSPh ; Michael J. Mugavero, MD, MHSc ; W. Christopher Mathews, MD, MSPH ; Carla V. Rodriguez, PhD ; Richard Moore, MD, MHS ; Joseph Eron, Jr., MD ; Sonia Napravnik, PhD ; Paul Crane, MD, MPH ; Peter Hunt, MD ; Priscilla Hsue, MD ; William Lober, MD ; Mari Kitahata, MD, MPH ; Michael S. Saag, MD ; Heidi M. Crane, MD, MPH

    333
    Covert Cognitive Impairment in Asymptomatic ART-Nave HIV-Infected Patients a Clinical and fMRI Study
    Haggai Sharon, MD ; Sari Ziv, MD ; Dan Turner, MD ; Talma Hendler, MD PhD ; David Hassin, MD
    Posters
  • Poster_Print.pdf (1.2 MB)

  • 334
    Early Effect of Antiretroviral Therapy on Markers of Innate Immune Activation in a Cohort of HIV-infected Patients
    Archana Maniar, M.D. ; Erin Hsu, MD ; Sumathi Sankaran, PhD ; David Asmuth, MD ; John Rutledge, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.